|
Edith Perez discusses the findings from the big adjuvent Herceptin trials on breastcancerupdate.com (or is it .org?).
She states that for the Her2 patients studied, there is no difference is stats between those who are on Tamox and those who are on an AI.
I think there's a lot more to be learned on this subject and there is very little that is well understood.
Me, I'm keeping my ovaries. I'm more afraid of the health consequences of losing them at a young age than I am a possible ovarian cancer.
Jen
__________________
dx 4/05 @ 34 y.o.
Stage IIIC, ER+ (90%)/PR+ (95%)/HER2+ (IHC 3+)
lumpectomy-- 2.5 cm 15+/37 nodes
(IVF in between surgery and chemo)
tx dd A/C, followed by dd Taxol & Herceptin
30 rads (or was it 35?)
Finished Herceptin on 7/24/06
Tamox
livingcured.blogspot.com
"Keep your face to the sunshine and you cannot see the shadow." -- Helen Keller
|